Status: AWMSG assessment in progress | |
For the off-label treatment of Immune Checkpoint Inhibitor (ICI) induced grade 3-4 myocarditis that has not responded to first line immunosuppression with corticosteroids. |
|
Medicine details |
|
Medicine name | infliximab |
Formulation | powder for solution for infusion |
Reference number | OW31 |
Indication | As above |
Company | various |
BNF chapter | Malignant disease & immunosuppression |
Submission type | One Wales |
Status | AWMSG assessment in progress |
Scrutiny Panel meeting date | 06/03/2025 |
OWMAG meeting date | TBC |
AWMSG meeting date | TBC |
Date of issue | TBC |